Tandem Diabetes Care Inc (TNDM) stock
TNDMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3030% below fair value
$17.05−0.01 (-0.06%)
Close on Nov 18, 2026Market cap $1.19BP/E –Yield –
Tandem Diabetes Care operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Tandem Diabetes Care's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.52M, down 156.8% year over year. For fiscal 2025 it was -$9.72M, down 140.1% from the year before. The highest annual figure on record is $111.36M in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$9.72M | -140.1% |
| FY2024 | Dec 31, 2024 | $24.23M | – |
| FY2023 | Dec 31, 2023 | -$31.81M | -163.0% |
| FY2022 | Dec 31, 2022 | $50.46M | -54.7% |
| FY2021 | Dec 31, 2021 | $111.36M | +351.4% |
| FY2020 | Dec 31, 2020 | $24.67M | -41.1% |
| FY2019 | Dec 31, 2019 | $41.91M | – |
| FY2018 | Dec 31, 2018 | -$8.32M | – |
| FY2017 | Dec 31, 2017 | -$66.14M | – |
| FY2016 | Dec 31, 2016 | -$61.17M | – |
| FY2015 | Dec 31, 2015 | -$58.76M | – |
| FY2014 | Dec 31, 2014 | -$61.38M | – |
| FY2013 | Dec 31, 2013 | -$47.76M | – |
| FY2012 | Dec 31, 2012 | -$33.47M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$34.63M | – |
| Q1 FY2026 | Mar 31, 2026 | $11.05M | – |
| Q4 FY2025 | Dec 31, 2025 | $9.79M | -8.7% |
| Q3 FY2025 | Sep 30, 2025 | $8.26M | -69.1% |
| Q2 FY2025 | Jun 30, 2025 | -$9.50M | – |
| Q1 FY2025 | Mar 31, 2025 | -$18.28M | – |
| Q4 FY2024 | Dec 31, 2024 | $10.72M | – |
| Q3 FY2024 | Sep 30, 2024 | $26.78M | +48589.1% |
| Q2 FY2024 | Jun 30, 2024 | -$5.28M | – |
| Q1 FY2024 | Mar 31, 2024 | -$8.00M | – |
| Q4 FY2023 | Dec 31, 2023 | -$7.22M | -224.0% |
| Q3 FY2023 | Sep 30, 2023 | $55.00K | -99.8% |
| Q2 FY2023 | Jun 30, 2023 | -$6.32M | -191.6% |
| Q1 FY2023 | Mar 31, 2023 | -$18.33M | -232.8% |
| Q4 FY2022 | Dec 31, 2022 | $5.82M | -70.4% |
| Q3 FY2022 | Sep 30, 2022 | $23.94M | -29.9% |
| Q2 FY2022 | Jun 30, 2022 | $6.90M | -76.1% |
| Q1 FY2022 | Mar 31, 2022 | $13.80M | -51.9% |
| Q4 FY2021 | Dec 31, 2021 | $19.64M | +28.9% |
| Q3 FY2021 | Sep 30, 2021 | $34.14M | +134.4% |
| Q2 FY2021 | Jun 30, 2021 | $28.90M | +86.4% |
| Q1 FY2021 | Mar 31, 2021 | $28.69M | – |
| Q4 FY2020 | Dec 31, 2020 | $15.24M | -21.6% |
| Q3 FY2020 | Sep 30, 2020 | $14.56M | -36.7% |
| Q2 FY2020 | Jun 30, 2020 | $15.50M | +334.4% |
| Q1 FY2020 | Mar 31, 2020 | -$20.63M | – |
| Q4 FY2019 | Dec 31, 2019 | $19.44M | +37.6% |
| Q3 FY2019 | Sep 30, 2019 | $23.02M | – |
| Q2 FY2019 | Jun 30, 2019 | $3.57M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.12M | – |
| Q4 FY2018 | Dec 31, 2018 | $14.13M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.46M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.72M | – |
| Q1 FY2018 | Mar 31, 2018 | -$12.27M | – |
| Q4 FY2017 | Dec 31, 2017 | -$11.64M | – |
| Q3 FY2017 | Sep 30, 2017 | -$19.02M | – |
| Q2 FY2017 | Jun 30, 2017 | -$14.67M | – |
| Q1 FY2017 | Mar 31, 2017 | -$20.81M | – |
| Q4 FY2016 | Dec 31, 2016 | -$13.58M | – |
| Q3 FY2016 | Sep 30, 2016 | -$18.15M | – |
See a number that looks wrong?